Akero Therapeutics Inc buy Cantor Fitzgerald
Start price
04.10.23
/
50%
€43.60
Target price
04.10.24
€65.81
Performance (%)
-42.11%
End price
02:15
-
Summary
This prediction is currently being closed. Massive losses of -42.11% have been the result for the BUY prediction by Cantor_Fitzgerald. Cantor_Fitzgerald has a follow-up prediction for Akero Therapeutics Inc where he still thinks Akero Therapeutics Inc is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | 1.660% | 1.660% | -42.072% |
| iShares Core DAX® | -1.114% | 3.430% | 25.966% |
| iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
| iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
| iShares S&P 500 | 2.038% | 5.327% | 30.881% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $69.00 price target on the stock.
Ratings data for AKRO provided by MarketBeat
In the thread Trading Akero Therapeutics Inc
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€13.80
11.10.23
11.10.23
€36.75
11.10.24
11.10.24
86.38%
04.10.24
04.10.24
Stopped prediction by Cantor_Fitzgerald for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€20.34
20.06.24
20.06.24
-
20.06.25
20.06.25
26.45%
04.10.24
04.10.24
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€48.20
19.09.23
19.09.23
€64.47
19.09.24
19.09.24
-48.36%
20.09.24
20.09.24